...
首页> 外文期刊>Molecular Genetics & Genomic Medicine >Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses
【24h】

Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses

机译:台湾患者粘多糖尿病患者的眼科表现

获取原文
           

摘要

Background Mucopolysaccharidoses (MPSs) are a group of rare lysosomal storage disorders characterized by the accumulation of glycosaminoglycans in various tissues and organs. Ocular problems that affect the cornea, trabecular meshwork, sclera, retina, and optic nerve are very common in these patients. However, there was limited literature focusing on comprehensive ocular findings in different types of MPS. Methods We retrospectively reviewed the clinical ophthalmologic features and electrodiagnostic results of 50 Taiwanese patients with a diagnosis of MPS (34 males and 16 females; age range, 1.1–34.9?years; nine with MPS I, 17 with MPS II, 17 with MPS IV, and seven with MPS VI). Results Among 44 patients with available data for visual acuity, 15 patients (34%) had a visual acuity of less than 0.5 (6/12) equivalent in their better eye, including 71% of those with MPS VI, 38% with MPS IV, 29% with MPS I, and 14% with MPS II. Severe corneal opacities existed in 57% of MPS VI patients and 11% of MPS I patients, compared with none for MPS II and MPS IV patients. Among 80 eyes with available data of refraction, 11 eyes (14%) had myopia (≦?0.50?D), 55 eyes (69%) had hyperopia (≧0.50?D), and 55 eyes (69%) had high astigmatism (≧1.50?D). Ocular hypertension was found in 45% (28/62) of eyes. There were 16% (14/90), 11% (10/90), 13% (12/90), 31% (27/86), and 79% (30/38) of MPS eyes with lens opacities, optic disc swelling, optic disc cupped, retinopathy, and visual pathway dysfunction, respectively. Intraocular pressure was positively correlated with the severity of corneal opacity ( p? ? 0.01). Conclusions Ocular complications with significant reduction in visual acuity are common in MPS patients. Diagnostic problems may arise in these patients with severe corneal opacification, especially for those with MPS VI and MPS I.
机译:背景技术粘性多糖(MPS)是一组稀有溶酶体储存障碍,其特征在于各种组织和器官中的糖胺聚糖的积累。影响角膜,小梁网状,巩膜,视网膜和视神经的眼部问题在这些患者中很常见。然而,在不同类型的MPS中综注着综合眼镜发现的文献有限。方法回顾性地审查了50名台湾患者的临床眼科特征和电源诊断患者的临床眼科特征和电源性诊断(34名男性和16名女性;年龄范围,1.1-34.9?年;九年九是MPS I,17款,带MPS II,17款和七个与MPS VI)。结果44名可用数据数据的可用数据,15名患者(34%)的视力低于0.5(6/12),其在其更好的眼睛中,包括71%的MPS VI,38%与MPS IV有38% ,29%,MPS I,14%,MPS II。严重的角膜不透射率为57%的MPS VI患者和11%的MPS I患者,与MPS II和MPS IV患者无非。在80只眼睛中,可用数据的折射数据,11只眼(14%)有近视(≤≤0.50≤d),55只眼(69%)有过多的超常见(≧0.50≤d),55只眼睛(69%)具有高散光(≧1.50?d)。在45%(28/62)的眼睛中发现眼高血压。有16%(14/90),11%(10/90),13%(12/90),31%(27/86)和79%(30/38)MPS眼睛,光学椎间盘膨胀,视镜盘杯,视网膜病变和视觉途径功能障碍。与角膜不透明度的严重程度呈正相关(P≤0.01)。结论在MPS患者中,视力显着降低的眼部并发症是常见的。这些严重角膜透露术患者可能会出现诊断问题,特别是对于具有MPS VI和MPS I的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号